Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer

Cell Reports Medicine - Tập 4 - Trang 101196 - 2023
Syeda Maheen Batool1, Tiffaney Hsia1, Alexandra Beecroft1, Brian Lewis1, Emil Ekanayake1, Yulia Rosenfeld1, Ana K. Escobedo1, Austin S. Gamblin1, Siddarth Rawal2,3, Richard J. Cote4,3, Mark Watson2, David T.W. Wong5, Abhijit A. Patel6, Johan Skog7, Nickolas Papadopoulos8, Chetan Bettegowda8, Cesar M. Castro9, Hakho Lee9, Sudhir Srivastava10, Bob S. Carter1
1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
2Washington University School of Medicine. St. Louis, Mo. USA
3Circulogix Inc., St. Louis, MO, USA
4Washington University School of Medicine, St. Louis, MO, USA
5University of California Los Angeles, Los Angeles, CA, USA
6Yale University School of Medicine, New Haven, CT, USA
7Exosome Diagnostics, Waltham, MA 02451, USA
8Johns Hopkins University School of Medicine, Baltimore, MD USA
9Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
10Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA

Tài liệu tham khảo

Neumann, 2018, ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress, Comput. Struct. Biotechnol. J., 16, 190, 10.1016/j.csbj.2018.05.002 Green, 2013, The cost of poor blood specimen quality and errors in preanalytical processes, Clin. Biochem., 46, 1175, 10.1016/j.clinbiochem.2013.06.001 2020 2020 Yu, 2021, Exosome-based liquid biopsies in cancer: opportunities and challenges, Ann. Oncol., 32, 466, 10.1016/j.annonc.2021.01.074 Lustberg, 2018, Implementing Liquid Biopsies in Clinical Trials: State of Affairs, Opportunities, and Challenges, Cancer J., 24, 61, 10.1097/PPO.0000000000000309 Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322 Bhawal, 2020, Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer, Cancers, 12, 2428, 10.3390/cancers12092428 Reinders, 2015 Tolstikov, 2020, Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics, Metabolites, 10, 224, 10.3390/metabo10060224 Danielson, 2016, Diurnal Variations of Circulating Extracellular Vesicles Measured by Nano Flow Cytometry, PLoS One, 11, e0144678, 10.1371/journal.pone.0144678 Frühbeis, 2015, Physical exercise induces rapid release of small extracellular vesicles into the circulation, J. Extracell. Vesicles, 4, 28239, 10.3402/jev.v4.28239 Michela, 2021, Liquid Biopsy: A Family of Possible Diagnostic Tools, Diagnostics, 11, 1391, 10.3390/diagnostics11081391 Tirumalai, 2003, Characterization of the low molecular weight human serum proteome, Mol. Cell. Proteomics, 2, 1096, 10.1074/mcp.M300031-MCP200 Tucholska, 2010, The endogenous peptides of normal human serum extracted from the acetonitrile-insoluble precipitate using modified aqueous buffer with analysis by LC-ESI-Paul ion trap and Qq-TOF, J. Proteonomics, 73, 1254, 10.1016/j.jprot.2010.02.022 Holewinski, 2013, A fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid, Proteomics, 13, 743, 10.1002/pmic.201200192 Qiu, 2015, Evaluation of two high-abundance protein depletion kits and optimization of downstream isoelectric focusing, Mol. Med. Rep., 12, 7749, 10.3892/mmr.2015.4417 Tomascova, 2019, A comparison of albumin removal procedures for proteomic analysis of blood plasma, Gen. Physiol. Biophys., 38, 305, 10.4149/gpb_2019009 Terracciano, 2006, Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles, Proteomics, 6, 3243, 10.1002/pmic.200500614 Blume, 2020, Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona, Nat. Commun., 11, 3662, 10.1038/s41467-020-17033-7 Anderson, 2006, Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins, Mol. Cell. Proteomics, 5, 573, 10.1074/mcp.M500331-MCP200 Darbeheshti, 2022, Pre-PCR Mutation-Enrichment Methods for Liquid Biopsy Applications, Cancers, 14, 3143, 10.3390/cancers14133143 Rossi, 2019, Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine, Cancer Res., 79, 2798, 10.1158/0008-5472.CAN-18-3402 Pittella-Silva, 2020, Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?, Clin. Chem., 66, 946, 10.1093/clinchem/hvaa103 Wong, 2016, Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approaches, Clin. Biochem., 49, 1379, 10.1016/j.clinbiochem.2016.09.009 El Messaoudi, 2013, Circulating cell free DNA: Preanalytical considerations, Clin. Chim. Acta, 424, 222, 10.1016/j.cca.2013.05.022 Thierry, 2010, Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts, Nucleic Acids Res., 38, 6159, 10.1093/nar/gkq421 Jung, 2003, Changes in concentration of DNA in serum and plasma during storage of blood samples, Clin. Chem., 49, 1028, 10.1373/49.6.1028 Umetani, 2006, Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation, Ann. N. Y. Acad. Sci., 1075, 299, 10.1196/annals.1368.040 Chan, 2005, Effects of preanalytical factors on the molecular size of cell-free DNA in blood, Clin. Chem., 51, 781, 10.1373/clinchem.2004.046219 Gautschi, 2004, Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy, J. Clin. Oncol., 22, 4157, 10.1200/JCO.2004.11.123 Agrawal, 2018, Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy, Semin. Cancer Biol., 52, 26, 10.1016/j.semcancer.2017.12.008 Christenson, 2012, Methodological and analytic considerations for blood biomarkers, Prog. Cardiovasc. Dis., 55, 25, 10.1016/j.pcad.2012.05.001 Augustus, 2020, The art of obtaining a high yield of cell-free DNA from urine, PLoS One, 15, e0231058, 10.1371/journal.pone.0231058 Bosschieter, 2018, A protocol for urine collection and storage prior to DNA methylation analysis, PLoS One, 13, e0200906, 10.1371/journal.pone.0200906 Cannas, 2009, Implications of storing urinary DNA from different populations for molecular analyses, PLoS One, 4, e6985, 10.1371/journal.pone.0006985 Milde, 1999, Improved DNA typing of human urine by adding EDTA, Int. J. Leg. Med., 112, 209, 10.1007/s004140050237 Li, 2019, New method to preserve the original proportion and integrity of urinary cell-free DNA, J. Clin. Lab. Anal., 33, e22668, 10.1002/jcla.22668 Erdbrügger, 2021, Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles, J Extracell Vesicles, 10, 10.1002/jev2.12093 Khurshid, 2018, Role of Salivary Biomarkers in Oral Cancer Detection, Adv. Clin. Chem., 86, 23, 10.1016/bs.acc.2018.05.002 Lousada-Fernandez, 2018, Liquid Biopsy in Oral Cancer, Int. J. Mol. Sci., 19, 1704, 10.3390/ijms19061704 Nonaka, 2018, Liquid Biopsy in Head and Neck Cancer: Promises and Challenges, J. Dent. Res., 97, 701, 10.1177/0022034518762071 Sullivan, 2020, An optimised saliva collection method to produce high-yield, high-quality RNA for translational research, PLoS One, 15, e0229791, 10.1371/journal.pone.0229791 Arunachalam, 2019, Isolation and Quantification of MicroRNAs from Human Saliva, Methods Mol. Biol., 2054, 105, 10.1007/978-1-4939-9769-5_6 Kaczor-Urbanowicz, 2019, Clinical validity of saliva and novel technology for cancer detection, Biochim. Biophys. Acta Rev. Canc, 1872, 49, 10.1016/j.bbcan.2019.05.007 Koopaie, 2022, Salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta-analysis, Cancer Med., 11, 2644, 10.1002/cam4.4640 Ventura, 2021, Is there difference in the comparative and quantitative salivary proteome between stimulated and unstimulated saliva in head and neck cancer patients treated by radiotherapy?, Oral Oncol., 118, 105315, 10.1016/j.oraloncology.2021.105315 Teunissen, 2009, A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking, Neurology, 73, 1914, 10.1212/WNL.0b013e3181c47cc2 Rodríguez-Lee, 2018, Effect of Blood Collection Tube Type and Time to Processing on the Enumeration and High-Content Characterization of Circulating Tumor Cells Using the High-Definition Single-Cell Assay, Arch. Pathol. Lab Med., 142, 198, 10.5858/arpa.2016-0483-OA Fleischhacker, 2020, Pre-analytical issues in liquid biopsy – where do we stand?, J. Lab. Med., 44, 117 Volckmar, 2018, A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications, Genes Chromosomes Cancer, 57, 123, 10.1002/gcc.22517 Salvianti, 2020, The pre-analytical phase of the liquid biopsy, N. Biotech., 55, 19, 10.1016/j.nbt.2019.09.006 Luk, 2017, CTC-mRNA (AR-V7) Analysis from Blood Samples-Impact of Blood Collection Tube and Storage Time, Int. J. Mol. Sci., 18, 1047, 10.3390/ijms18051047 Zhao, 2019, Performance comparison of blood collection tubes as liquid biopsy storage system for minimizing cfDNA contamination from genomic DNA, J. Clin. Lab. Anal., 33, e22670, 10.1002/jcla.22670 McEwen, 2020, Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors, Front. Cell Dev. Biol., 8, 45, 10.3389/fcell.2020.00045 von Baumgarten, 2020, Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy, Theranostics, 10, 856, 10.7150/thno.36884 Huang, 2017, Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma, Acta Neuropathol. Commun., 5, 28, 10.1186/s40478-017-0436-6 Mattox, 2019, The potential of cerebrospinal fluid–based liquid biopsy approaches in CNS tumors, Neuro Oncol., 21, 1509, 10.1093/neuonc/noz156 Van Paemel, 2020, Genome-wide study of the effect of blood collection tubes on the cell-free DNA methylome, Epigenetics, 16, 797, 10.1080/15592294.2020.1827714 Henson, 2010, Collection, storage, and processing of saliva samples for downstream molecular applications, Methods Mol. Biol., 666, 21, 10.1007/978-1-60761-820-1_2 Sato, 2018, Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy, Oncotarget, 9, 31904, 10.18632/oncotarget.25881 Mariner, 2018, Improved Detection of Circulating miRNAs in Serum and Plasma Following Rapid Heat/Freeze Cycling, MicroRNA, 7, 138, 10.2174/2211536607666180416152112 Gerber, 2020, Assessment of Pre-Analytical Sample Handling Conditions for Comprehensive Liquid Biopsy Analysis, J. Mol. Diagn., 22, 1070, 10.1016/j.jmoldx.2020.05.006 Wu, 2020, Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma, Int. J. Biol. Sci., 16, 1551, 10.7150/ijbs.44024 Slowey, 2017, Salivary Diagnostics Using Purified Nucleic Acids, Methods Mol. Biol., 1537, 3, 10.1007/978-1-4939-6685-1_1 Snow, 2019, The current status of the clinical utility of liquid biopsies in cancer, Expert Rev. Mol. Diagn., 19, 1031, 10.1080/14737159.2019.1664290 Krol, 2018, Detection of circulating tumour cell clusters in human glioblastoma, Br. J. Cancer, 119, 487, 10.1038/s41416-018-0186-7 Porras, 2018, Challenges in using liquid biopsies for gene expression profiling, Oncotarget, 9, 7036, 10.18632/oncotarget.24140 Saugstad, 2017, Analysis of extracellular RNA in cerebrospinal fluid, J. Extracell. Vesicles, 6, 1317577, 10.1080/20013078.2017.1317577 Tong, 2016, Evaluating the impact of sequencing error correction for RNA-seq data with ERCC RNA spike-in controls, IEEE. EMBS. Int. Conf. Biomed. Health Inform., 2016, 74 Craig, 2019, Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells, BMC Cancer, 19, 1081, 10.1186/s12885-019-6313-x Gholami, 2018, Design and Development of a Quantitative TaqMan Real-Time PCR Assay for Evaluation of HIV-1 (group M) Viral Load in Plasma Using Armored RNA Standard, Clin. Lab., 64, 955, 10.7754/Clin.Lab.2018.171215